Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a…
Tenable Announces Third Quarter 2025 Financial Results
Tenable Exceeds Q3 Revenue and Profit Expectations, Raises Full-Year Outlook Revenue of…
Climb Global Solutions Reports Third Quarter 2025 Results
EATONTOWN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc.…
FormFactor, Inc. Reports 2025 Third Quarter Results
Q3 Revenue, Gross Margin and Earnings per Share Exceed the Midpoint of…
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing…
Supermicro, Intel and Micron Collaborate on Record-Breaking Results for the STAC-M3 Quantitative Trading Benchmark
The STAC-M3 measures time-series database performance used in algorithmic trading and backtesting…
Varonis Announces Third Quarter 2025 Financial Results
Annual recurring revenues increased 18% year-over-yearSaaS ARR as a percentage of total…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in…
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 23, 2025 13:08 ET | Source: Progyny, Inc. NEW YORK, Oct.…
